Free Radical Injury and Oxidative Stress

Generation of Reactive Oxygen Species

• Superoxide anion (O₂•⁻): Generated primarily by mitochondrial electron transport chain (Complexes I and III), NADPH oxidase in phagocytes, and xanthine oxidase; undergoes dismutation to H₂O₂ via superoxide dismutase (SOD)
• Hydrogen peroxide (H₂O₂): Formed from superoxide dismutation; crosses cell membranes; converted to H₂O by catalase and glutathione peroxidase (GPx)
• Hydroxyl radical (OH•): Most reactive ROS; generated via Fenton reaction (Fe²⁺ + H₂O₂ → Fe³⁺ + OH• + OH⁻); cannot be enzymatically degraded; primarily scavenged by organic molecules
• Hypochlorous acid (HOCl): Generated by myeloperoxidase (MPO) in neutrophils; potent antimicrobial but also causes collateral tissue damage
• Peroxynitrite (ONOO⁻): Formed from reaction of superoxide with nitric oxide (NO); powerful oxidant and nitrating agent causing protein modification

Mechanisms of Cellular Damage

• Lipid Peroxidation: Free radicals abstract hydrogen atoms from polyunsaturated fatty acids in cell membranes and organellar membranes, initiating chain reactions that generate lipid hydroperoxides and malondialdehyde (MDA); results in membrane rigidity, loss of fluidity, increased permeability, and organellar dysfunction
• Protein Oxidation: Radicals cause covalent cross-linking, fragmentation, and conformational changes in proteins; particularly affects sulfhydryl groups (-SH) in cysteine and methionine residues; inactivates enzymes and structural proteins; generates protein carbonyls (detectable biomarkers)
• DNA Damage: Direct radical attack causes strand breaks (single and double), base modifications (8-oxoguanine most common), and thymine dimers; indirect damage via ROS-mediated activation of nucleases; leads to mutagenesis, apoptosis, or senescence; accumulation in mtDNA causes mitochondrial dysfunction
• Mitochondrial Dysfunction: ROS impair oxidative phosphorylation, reduce ATP production, damage cardiolipin (inner membrane lipid), and trigger cytochrome c release via permeability transition pore (PTP) opening, activating intrinsic apoptotic pathway

Antioxidant Defense Systems

• Enzymatic defenses: Superoxide dismutase (SOD1, SOD2, SOD3) catalyzes superoxide dismutation; catalase degrades H₂O₂ to water and oxygen; glutathione peroxidase uses glutathione (GSH) to reduce H₂O₂ and organic hydroperoxides
• Non-enzymatic defenses: Glutathione (GSH) is primary intracellular antioxidant (regenerated via glutathione reductase); vitamin E (α-tocopherol) lipophilic antioxidant in membranes; vitamin C (ascorbic acid) aqueous antioxidant; carotenoids and selenium cofactors for GPx
• Metal chelation: Ceruloplasmin and transferrin bind free iron and copper, preventing Fenton reactions; ferritin sequesters iron

Ischemia-Reperfusion Injury—Paradigmatic Example

Exogenous Sources

• Environmental toxins: Cigarette smoke, air pollution (particulate matter), heavy metals (cadmium, lead, mercury causing Fenton reactions), pesticides
• Ionizing radiation: UV radiation, gamma radiation, X-rays cause direct free radical production and water radiolysis generating hydroxyl radicals
• Medications and chemicals: Acetaminophen, bleomycin, adriamycin (chemotherapy-related), paraquat (herbicide), dioxins
• Dietary factors: High-fat diet oxidation, trans fats, alcohol (acetaldehyde metabolism), iron and copper overload

Endogenous/Pathological Sources

• Ischemia-reperfusion: Myocardial infarction, stroke, organ transplantation, trauma-hemorrhage-resuscitation
• Inflammation: Activated neutrophils and macrophages produce massive ROS via NADPH oxidase and MPO during innate immune response; contributes to collateral tissue damage
• Mitochondrial dysfunction: Genetic mutations (mtDNA), aging, metabolic stress impairing electron transport chain
• Metabolic disorders: Diabetes mellitus (hyperglycemia drives ROS via multiple pathways including glycation and PKC activation), obesity, dyslipidemia
• Infections: Pathogen-associated molecular patterns (PAMPs) activate NADPH oxidase in phagocytes; bacterial endotoxins and viral proteins generate ROS
• Aging: Progressive mitochondrial dysfunction, accumulated protein aggregates, declining antioxidant capacity
• Genetic conditions: Familial hypercholesterolemia (atherosclerosis), hemophilia A/B (ischemic complications), antioxidant enzyme deficiencies (SOD1 mutations cause ALS)

Organ-Specific Risk States

• CNS: Excitotoxicity (glutamate excess), Parkinson disease (dopamine metabolism), Alzheimer disease (amyloid-β and tau)
• Cardiac: Heart failure, myocarditis, diabetic cardiomyopathy
• Pulmonary: ARDS, oxygen toxicity, idiopathic pulmonary fibrosis
• Hepatic: Alcoholic liver disease, NAFLD, viral hepatitis, acetaminophen toxicity
• Renal: Diabetic nephropathy, glomerulonephritis, drug-induced nephrotoxicity

Acute Presentations

• Ischemia-Reperfusion Injury: Sudden-onset tissue dysfunction (myocardial infarction with chest pain/dyspnea, acute stroke with neurological deficits, acute kidney injury with oliguria) following restoration of blood flow; reperfusion paradox where symptoms worsen despite reflow; manifests as arrhythmias, cardiogenic shock, neurological deterioration despite angiographic success
• Acute Respiratory Distress Syndrome (ARDS): Acute lung injury from sepsis, aspiration, or trauma; presents with refractory hypoxemia, bilateral infiltrates, and pulmonary edema; driven by neutrophil-derived ROS causing alveolar-capillary membrane disruption
• Acute Liver Failure: Following acetaminophen overdose or acute viral hepatitis; hepatocellular necrosis leads to encephalopathy, coagulopathy, and fulminant hepatic failure; ROS causes mitochondrial dysfunction and apoptosis

Chronic/Degenerative Presentations

• Atherosclerosis and Cardiovascular Disease: LDL oxidation (OxLDL) triggers endothelial dysfunction, foam cell formation, and plaque development; presents with angina pectoris, myocardial infarction, or peripheral vascular disease; oxidative stress increases with age and risk factors
• Neurodegenerative Diseases:
• Parkinson disease: Dopamine metabolism generates ROS; loss of substantia nigra dopaminergic neurons causes bradykinesia, rigidity, tremor; Lewy bodies accumulate partly due to oxidative damage
• Alzheimer disease: Amyloid-β aggregates generate ROS; tau hyperphosphorylation worsened by oxidative stress; progressive cognitive decline and memory loss
• ALS: Motor neuron degeneration from SOD1 mutations impairing superoxide scavenging; progressive weakness and paralysis
• Diabetes Complications: Hyperglycemia drives ROS through NADPH oxidase, mitochondrial electron transport, and advanced glycation end products (AGEs); manifests as retinopathy (vision loss), nephropathy (proteinuria/renal failure), neuropathy (paresthesias/pain), accelerated atherosclerosis
• Pulmonary Fibrosis: Chronic ROS exposure (asbestos, smoking, radiation) activates fibroblasts; progressive dyspnea, restrictive pattern on PFTs, honeycomb fibrosis on imaging
• Cancer: Chronic oxidative stress drives mutagenesis and malignant transformation; paradoxically, cancer cells often have elevated ROS handled by upregulated antioxidants—creating therapeutic opportunity with pro-oxidant drugs
• Aging and Cellular Senescence: Cumulative oxidative damage causes telomere shortening, mitochondrial dysfunction, and protein aggregate accumulation; manifests as systemic aging phenotype

Laboratory/Diagnostic Findings

• Elevated cardiac biomarkers (troponin, CK-MB) in ischemia-reperfusion injury
• Elevated transaminases (ALT, AST) and bilirubin in acute liver injury
• Elevated serum creatinine and urea in acute kidney injury
• Elevated LDH reflecting cellular necrosis
• Prolonged PT/INR in acute liver failure from impaired synthetic function

Biomarkers of Oxidative Stress

• Direct ROS detection: Electron spin resonance (ESR) spectroscopy can directly detect free radicals in tissue samples (research primarily); fluorescent probes (dichlorofluorescin-diacetate, dihydroethidium) used experimentally to visualize ROS in cells
• Lipid peroxidation markers: Malondialdehyde (MDA) elevated in serum/tissue; thiobarbituric acid reactive substances (TBARS) assay measures lipid peroxides; oxidized linoleic acid metabolites (OXLAMs) in plasma
• Protein oxidation markers: Protein carbonyls detected via immunohistochemistry or ELISA; 3-nitrotyrosine from peroxynitrite-mediated nitration visible on immunostains; 8-oxoguanine in genomic and mitochondrial DNA
• Antioxidant enzyme assessment: Serum superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx) levels; reduced glutathione (GSH):oxidized glutathione (GSSG) ratio indicates oxidative stress
• Inflammatory markers reflecting ROS-driven inflammation: C-reactive protein (CRP), TNF-α, IL-6, elevated in ischemia-reperfusion and sepsis

Histopathological Findings

• Acute Necrosis: Zone of ischemia-reperfusion shows coagulative necrosis with hypereosinophilic cytoplasm, nuclear pyknosis/karyorrhexis, loss of cell boundaries; contraction band necrosis in myocardium (dark-staining bands of hypercontracted sarcomeres)
• Oxidative Damage Immunostains: 8-oxoguanine staining highlights DNA oxidation; 3-nitrotyrosine and 4-hydroxynonenal (4-HNE) immunostaining demonstrate protein and lipid peroxidation; carbonyl groups detected via dinitrophenyl hydrazone antibodies
• Mitochondrial Pathology: Electron microscopy shows mitochondrial swelling, cristae disruption, electron-dense deposits; loss of normal organized cristae architecture
• Inflammation: Acute inflammatory infiltrate with neutrophils and macrophages releasing additional ROS; reactive oxygen species-positive cells on DHE staining

Gross Pathology Findings

• Ischemia-reperfusion injury: Reperfused organ shows pallor followed by hyperemia (hemorrhagic infarction in some tissues); myocardial infarcts appear tan-yellow with hemorrhagic border; brain shows edema and potential hemorrhage
• Liver necrosis: Centrilobular or massive hepatic necrosis appears as yellow-brown discoloration with hemorrhage
• Atherosclerotic plaques: Lipid-rich plaques with oxidized LDL accumulation appear as focal intimal thickening

Diagnostic Criteria/Approach

1. 1.Clinical context assessment: Identify ischemia-reperfusion risk (surgery, angioplasty, acute MI), inflammatory condition (sepsis), metabolic disease (diabetes), or environmental exposure (smoking, radiation)
2. 2.Biomarker confirmation: Elevated oxidative stress markers (MDA, protein carbonyls, 8-oxoguanine) and/or reduced antioxidants (SOD, catalase, GSH)
3. 3.Tissue evaluation: Histology showing appropriate pattern of necrosis or degeneration; immunostains for oxidative damage markers
4. 4.Functional assessment: Enzyme levels (troponin, transaminases), organ dysfunction markers (creatinine, bilirubin)
5. 5.Imaging correlation: MRI/CT demonstrating acute ischemic changes, organ edema, or structural damage pattern consistent with ROS-mediated injury

Special Diagnostic Scenarios

• Mitochondrial disease suspected: Mitochondrial DNA (mtDNA) mutations identified via genetic testing; respiratory chain enzyme activities reduced on muscle biopsy
• Antioxidant enzyme deficiency: SOD1 mutations in ALS identified via genetic sequencing; functional enzyme assays show reduced activity
• Drug-induced oxidative injury: History of chemotherapy (adriamycin, bleomycin) or acetaminophen overdose; elevated biomarkers confirm diagnosis

Therapeutic Strategy—Antioxidant Replenishment

First-Line Treatments

• Oxygen limitation in reperfusion settings: Minimize FiO₂ and duration of hyperoxia during resuscitation (target SpO₂ 94-98% rather than 100%); reduces mitochondrial ROS generation while maintaining tissue oxygenation; particularly important in ischemia-reperfusion injury
• Antioxidant vitamins:
• Vitamin C (ascorbic acid) at 1-2 g daily aqueous-phase antioxidant; reduces lipid peroxidation, regenerates other antioxidants; limited oral bioavailability but IV forms achieve higher tissue levels
• **Vitamin E (α-tocophe

Reperfusion-related complications (several are emergencies)

• Reperfusion arrhythmias: ROS-mediated sarcolemmal lipid peroxidation and Ca²⁺ overload create triggered activity within minutes of reflow; the feared endpoints are ventricular fibrillation / pulseless VT — a cardiac arrest emergency requiring immediate defibrillation per the AHA ACLS algorithm.
• Myocardial stunning and "no-reflow": ROS injure contractile proteins and microvascular endothelium; signaled by persistent wall-motion abnormality or TIMI grade 0–1 myocardial blush despite a patent epicardial artery. Contraction band necrosis is the histologic counterpart.
• Hemorrhagic transformation of infarct: oxidative degradation of the blood–brain barrier (MMP activation, peroxynitrite) after thrombolysis or thrombectomy; heralded by abrupt neurologic decline or headache — an emergency requiring stat non-contrast CT and reversal per AHA/ASA acute stroke guidance.
• Post-revascularization limb/crush syndrome: reperfused ischemic muscle releases K⁺, myoglobin, and ROS; rising creatine kinase, tea-colored urine, peaked T waves, and a tense compartment signal hyperkalemia, myoglobinuric AKI, and compartment syndrome — all emergent (fasciotomy, aggressive isotonic fluids).
• ARDS/systemic inflammatory response: neutrophil NADPH oxidase and myeloperoxidase products disrupt the alveolar–capillary membrane; refractory hypoxemia with bilateral infiltrates.

Complications of oxidant exposure and of therapy

• Acetaminophen fulminant hepatic failure: NAPQI depletes glutathione; encephalopathy plus rising INR is an emergency — AASLD acute liver failure guidance directs early transplant-center transfer.
• Oxygen toxicity in neonates: retinopathy of prematurity and bronchopulmonary dysplasia; AAP/AAO/AAPOS mandate ROP screening exams in at-risk preterm infants.
• Chemotherapy oxidant injury: bleomycin pulmonary fibrosis (declining DLCO), anthracycline cardiomyopathy from iron–ROS complexes (falling LVEF on surveillance echo; dexrazoxane, an iron chelator, is the cardioprotectant).
• N-acetylcysteine anaphylactoid reaction: non-IgE histamine release with flushing/wheeze during IV loading — slow or hold the infusion, treat, then resume; it is not a true allergy.
• Antioxidant supplement harms: high-dose vitamin C can cause oxalate nephropathy; the USPSTF recommends against beta-carotene or vitamin E supplements for cardiovascular or cancer prevention, and beta-carotene increased lung cancer in smokers.

• Hydroxyl radical is the villain: generated by the Fenton reaction (Fe²⁺ + H₂O₂) and by radiolysis of water after ionizing radiation. It has no enzymatic scavenger — catalase and glutathione peroxidase act on H₂O₂, not OH•. A stem offering "catalase degrades the hydroxyl radical" is the classic distractor.
• Contraction band necrosis is the reperfusion buzzword: hypercontracted eosinophilic sarcomere bands from Ca²⁺ influx into reoxygenated myocytes. Seen after thrombolysis/PCI and around infarct margins; also in cocaine toxicity and catecholamine excess.
• Acetaminophen → NAPQI → glutathione depletion: the single best next step in suspected overdose is N-acetylcysteine, which replenishes glutathione. Plot a single acute ingestion with a known time on the Rumack-Matthew nomogram, but give NAC empirically when timing is unknown, ingestion is staggered, or presentation is late — never delay for a level.
• CCl₄ → CCl₃• free radical in hepatocyte smooth ER: membrane lipid peroxidation blocks apolipoprotein secretion → fatty change with centrilobular necrosis. The classic "dry-cleaning worker" vignette.
• NADPH oxidase cuts both ways: its deficiency causes chronic granulomatous disease (abnormal dihydrorhodamine flow cytometry, historically nitroblue tetrazolium; catalase-positive organisms such as Staphylococcus aureus, Serratia, Burkholderia, Nocardia, Aspergillus). Myeloperoxidase deficiency gives a normal respiratory burst but abnormal MPO-dependent killing, with Candida susceptibility.
• Oxidant stress in RBCs: G6PD deficiency loses NADPH for glutathione regeneration → Heinz bodies and bite cells after dapsone, primaquine, sulfonamides, nitrofurantoin, or fava beans.
• The one association examiners love: SOD1 mutations in familial ALS, plus lipofuscin as the "wear-and-tear" pigment of lipid peroxidation residue in aging heart, liver, and neurons.
• Antioxidant supplements are not therapy: the USPSTF recommends against beta-carotene (which increased lung cancer in smokers) and vitamin E for cardiovascular or cancer prevention. In post-arrest care the AHA advises titrating oxygen to avoid hyperoxia rather than giving 100% FiO₂.